Concepedia

James Tollitt

JT

10

Publications

342

Citations

10

H-Index

2018

Active since

Affiliations

University of Manchester(Current)

Salford Royal NHS Foundation Trust

University Hospitals of Leicester NHS Trust

University of Leicester

Imperial College London

James Tollitt is an author at University of Manchester specializing in vaccine development, vaccine safety, and covid-19.

ORCID

Top concepts

Publications per year

2018–2024

10

Publications

10

Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasets

Kunihiro Matsushita, Simerjot K Jassal, Yingying Sang et al. · EClinicalMedicine · 2020 · 107 citations · Full text

Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

Kunihiro Matsushita, Stephen Kaptoge, Steven H J Hageman et al. · European Journal of Preventive Cardiology · 2022 · 70 citations · Full text

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2

J. Park, Fatai S. Oladunni, Mohammed A. Rohaim et al. · iScience · 2021 · 54 citations · Full text

, , +14

Cognitive impairment in patients with moderate to severe chronic kidney disease: the Salford kidney cohort study

James Tollitt, Aghogho Odudu, Daniela Montaldi et al. · Clinical Kidney Journal · 2020 · 22 citations · Full text

Impact of prior stroke on major clinical outcome in chronic kidney disease: the Salford kidney cohort study

James Tollitt, Aghogho Odudu, Emma Flanagan et al. · BMC Nephrology · 2019 · 18 citations · Full text

Rows per page

1–5 of 10